Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Total Debt for 3 consecutive years, with $10.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Debt fell 12.53% year-over-year to $10.5 million in Q4 2025; TTM through Dec 2025 was $10.5 million, a 12.53% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 12.53% from the prior year.
• Total Debt was $10.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $11.9 million in the prior quarter.
• Over five years, Total Debt peaked at $12.5 million in Q4 2023 and troughed at $10.5 million in Q4 2025.
• A 3-year average of $11.7 million and a median of $11.9 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt retreated 3.58% in 2024 and decreased 12.53% in 2025, its largest moves.
• Over 3 years, Total Debt stood at $12.5 million in 2023, then slipped by 3.58% to $12.0 million in 2024, then declined by 12.53% to $10.5 million in 2025.
• The last three Total Debt figures came in at $10.5 million (Q4 2025), $11.9 million (Q2 2025), and $12.0 million (Q4 2024), per Business Quant data.